Final thoughts:
The Breast Imaging market is predicted to experience growth in DBT systems, while the demand for FFDM systems is expected to decline in mature markets. Globally, the FFDM market is predicted to see a modest growth driven by digitalisation of developing countries, the introduction of novel screening programmes, and increased breast cancer awareness.
The global breast imaging market is predicted to remain flat in 2024, with DBT and ultrasound leading the 5-year forecast in terms of revenue growth. Supplementary screening modalities, such as GE HealthCare with their Invenia ABUS system, will provide increasing returns, as legislation supporting supplementary screening increases. Contrast-enhanced mammography capabilities are also likely to become an industry standard for gantries, given their quicker acquisition and interpretation by radiologists compared to MR scans, which are often prioritised for other exams and therefore unavailable for breast imaging.
In developing markets, system pricing and cost of ownership is a key determinant for decision-making as healthcare budgets are continually threatened by inflationary pressures. Vendors offering competitive prices, such as Fujifilm, are expected to achieve considerable success, especially in winning tenders, ultimately leading to lucrative service contracts to provide consistent returns on systems.
About the author: Having graduated from the University of Bristol with a BSc in Pharmacology, Max joined the Medical Imaging team at Signify Research in 2023, focusing on the X-ray market. Signify Research’s Medical Imaging team formulates expert market intelligence for some of the leading Ultrasound, CT, MR, and X-ray vendors. Combining primary data collection and in-depth discussions with industry stakeholders, our thorough research approach yields credible quantitative and qualitative analysis, helping our customers make critical business decisions with confidence. Furthermore, our commitment to seeking a plurality of perspectives across the markets we cover guarantees that our insights remain independent and balanced.
Signify Research provides healthtech market intelligence powered by data that you can trust. We blend insights collected from in-depth interviews with technology vendors and healthcare professionals with sales data reported to us by leading vendors to provide a complete and balanced view of the market trends. Our coverage areas are Medical Imaging, Clinical Care, Digital Health, Diagnostic and Lifesciences and Healthcare IT.Back to HCB News
